केरल में निपाह वायरस की दस्तक, जानें यह कैसे फैलता है और कितना खतरनाक?

केरल में निपाह वायरस की दस्तक, जानें यह कैसे फैलता है और कितना खतरनाक?


Nipah Outbreak in Kerala: केरल में निपाह वायरस का एक नया मामला सामने आया है‌. कोझिकोड में किए गए जांच में एक 45 वर्षीय व्यक्ति में निपाह वायरस की पुष्टि की गई है. यह मामला सामने आने के बाद स्वास्थ्य अधिकारियों ने एहतियात कदम उठाए और उस आदमी के कांटेक्ट में आए लोगों की पहचान शुरू कर दी. मरीज का फिलहाल कोझिकोड मेडिकल कॉलेज हॉस्पिटल में इलाज चल रहा है. ऐसे में चलिए अब आपको बताते हैं कि निपाह वायरस कैसे फैलता है और यह कितना खतरनाक है.

77 लोगों के कांटेक्ट में आया मरीज 

रिपोर्ट के अनुसार, राहत की बात यह है कि अभी तक मरीज के कांटेक्ट में आए 77 लोगों में से किसी में भी निपाह वायरस के कोई लक्षण दिखाई नहीं दिए. वहीं अधिकारियों के अनुसार, 77 लोगों में से 14 तो मरीज के परिवार के सदस्य, 5 दोस्त और कलीग और 58 स्वास्थ्य कर्मी शामिल हैं. बताया जा रहा है कि इनमें से 15 लोगों को अति-जोखिम वाली कैटेगरी में रखा गया है. 

क्या है निपाह वायरस? 

निपाह वायरस एक जेनेटिक वायरस है, यानी यह जानवरों से इंसानों में फैलता है. इसका मुख्य सोर्स फ्रूट वेट यानी फल खाने वाले चमगादड़ माने जाते हैं. यह वायरस पहली बार 1999 में मलेशिया और सिंगापुर में सामने आया था. इसके अलावा भारत, बांग्लादेश और दक्षिण पूर्व एशिया के कुछ देशों में समय- समय पर इसका प्रकोप देखने को मिला है. 

कैसे फैलता है निपाह वायरस?

निपाह वायरस का इन्फेक्शन इंसानों में कई तरह से फैल सकता है, जैसे संक्रमित चमगादड़ों की लार, पेशाब या मल से दूषित फल खाने पर, कच्चा खजूर का रस पीने पर जो चमगादड़ के कांटेक्ट में आया हो, इन्फेक्टेड जानवरों खासकर सूअरों के कांटेक्ट में आने से, उसके अलावा इन्फेक्टेड मरीज की बॉडी फ्लुइड्स जैसे लार, खून या दूसरे स्राव के कांटेक्ट में आने पर यह वायरस फैलता है. एक्सपर्ट्स के अनुसार संक्रमित मरीजों की देखभाल करने वाले लोगों में इसके इन्फेक्शन का खतरा ज्यादा रहता है. 

ये भी पढ़ें-Kitchen Hazards: आपकी आंखें खराब कर रहीं किचन में रखी ये तीन चीजें, आज ही दिखा दें बाहर का रास्ता

क्या है निपाह वायरस के लक्षण? 

इंफेक्शन के 4 से 14 दिन बाद इस वायरस के लक्षण दिखाई दे सकते हैं. शुरुआती लक्षण सामान्य वायरल संक्रमण जैसे होते हैं. इसमें तेज बुखार, सिर दर्द, मांसपेशियों में दर्द, कमजोरी, खांसी और गले में खराश, सांस लेने में परेशानी जैसे लक्षण दिखाई देते हैं. ज्यादा खतरनाक मामलों में वायरस दिमाग तक पहुंच सकता है और ब्रेन इन्फ्लेमेशन का कारण बन सकता है. वहीं विश्व स्वास्थ्य संगठन के अनुसार निपाह वायरस से संक्रमित 40 से 75 प्रतिशत मरीजों की मौत हो सकती है.

ये भी पढ़ें-Pericardial Effusion: हार्ट और पेट में क्यों भर जाता है पानी? रोजाना की इन गलतियों से हो सकता है गंभीर नुकसान

Check out below Health Tools-
Calculate Your Body Mass Index ( BMI )

Calculate The Age Through Age Calculator



Source link

Cancer: NPPA raises price cap on key drugs amid shortage

Cancer: NPPA raises price cap on key drugs amid shortage


The ceiling rate for cisplatin was raised to ₹10.89 ($0.1144) ​per ml from ₹7.26, while that for carboplatin was increased to ₹90.74 ($0.9530) per ml from ₹60.49 excluding taxes, the notification showed.

India’s drug price regulator raised ceiling rates for two key platinum-based cancer drugs ​by 50 per cent after a surge in raw material costs triggered ‌widespread shortages, according to a government notification seen ​by Reuters.

The National Pharmaceutical Pricing Authority (NPPA) invoked special provisions ⁠to raise rates for the drugs after receiving federal government approval citing public interest, according to the notification dated June 11.

Patients ‌in the world’s most populous country have been grappling with shortages of platinum-based cancer drugs cisplatin ‌and carboplatin, as hospitals, especially government-run facilities, run ‌short.

The ⁠prices of the drugs, used to treat ⁠ovarian, lung and bladder cancers, are capped and controlled by the government.

The ceiling rate for cisplatin was raised to ₹10.89 ($0.1144) ​per ml from ₹7.26, while that for carboplatin was increased to ₹90.74 ($0.9530) per ml from ₹60.49 excluding taxes, the notification showed.

“…The authority noted concerns regarding shortage ‌and supply disruptions of carboplatin and cisplatin formulations, which are ​essential oncology medicines used in the treatment of various cancers,” the NPPA said, adding ⁠that their uninterrupted availability is critical for public health.

The drugs are manufactured by several companies, including Cipla, Intas Pharmaceuticals ‌and oncology-focused firms such as Naprod Life Sciences and Venus Remedies.

The increase is a one-time revision and will be reviewed after six months, the NPPA said.

India is heavily dependent on imported platinum, which is used in industries ranging from automobiles and jewellery to chemicals and ‌pharmaceuticals.

Supplies of the white metal from key producers such as ​South Africa have dwindled amid soaring costs, while the West Asia conflict has further disrupted supply ⁠chains and raised manufacturing expenses, doctors and industry executives have told ⁠Reuters.

The increase on drug price caps offers relief to medicine makers who had temporarily halted production ‌as platinum prices more than doubled amid tight supplies, strong demand and shrinking inventories.

Published on June 12, 2026



Source link

Volumes soar at United Spirits Ltd counter

Volumes soar at United Spirits Ltd counter


United Spirits Ltd recorded volume of 6.28 lakh shares by 10:46 IST on BSE, a 18.62 times surge over two-week average daily volume of 33729 shares

Allied Blenders & Distillers Ltd, Indus Towers Ltd, Authum Investment & Infrastructure Ltd, Bajaj Holdings & Investment Ltd are among the other stocks to see a surge in volumes on BSE today, 12 June 2026.

United Spirits Ltd recorded volume of 6.28 lakh shares by 10:46 IST on BSE, a 18.62 times surge over two-week average daily volume of 33729 shares. The stock gained 0.70% to Rs.1,267.00. Volumes stood at 16945 shares in the last session.

 

Allied Blenders & Distillers Ltd notched up volume of 2.56 lakh shares by 10:46 IST on BSE, a 10.91 fold spurt over two-week average daily volume of 23483 shares. The stock rose 2.87% to Rs.625.80. Volumes stood at 1.12 lakh shares in the last session.

Indus Towers Ltd saw volume of 10.65 lakh shares by 10:46 IST on BSE, a 6.79 fold spurt over two-week average daily volume of 1.57 lakh shares. The stock increased 1.66% to Rs.419.85. Volumes stood at 52517 shares in the last session.

Authum Investment & Infrastructure Ltd clocked volume of 1.19 lakh shares by 10:46 IST on BSE, a 6.54 times surge over two-week average daily volume of 18241 shares. The stock gained 11.45% to Rs.511.95. Volumes stood at 5217 shares in the last session.

Bajaj Holdings & Investment Ltd notched up volume of 25500 shares by 10:46 IST on BSE, a 4.72 fold spurt over two-week average daily volume of 5397 shares. The stock rose 1.01% to Rs.9,960.00. Volumes stood at 896 shares in the last session.

Powered by Capital Market – Live News



Source link

Don't know if Claude AI used in strike at Iran school: Anthropic CEO

Don't know if Claude AI used in strike at Iran school: Anthropic CEO



By Katrina Manson and Emily Chang

 


Anthropic PBC’s boss said he doesn’t know what role his artificial intelligence model played in a missile strike that killed an estimated 120 children at an elementary school in Iran, reflecting a broader knowledge gap for AI executives who are increasingly selling advanced AI tools to the US military. 


But he said the use case in this instance didn’t violate the company’s policies, arguing military decision makers make terrible mistakes even at the best of times. 

 


“Look, we don’t have access to, we don’t know exactly how these models were used,” Dario Amodei, Anthropic’s CEO and cofounder told Bloomberg’s The Circuit with Emily Chang in an interview, when asked whether his company’s AI tool Claude played a role in the February 28 strike — the first day of US operations in Iran — on the school in Minab. He described the strike against the school as “a really terrible thing to happen.” 

 
 


“The principle that we have established, and I think the principle that was obeyed here, is a human makes the final decision,” Amodei said. “I don’t know what role Claude or any other AI had, but if this isn’t an illustration why that principle is so important, I don’t know what is.” 

 


The Pentagon, which hasn’t publicly claimed responsibility for the strike, is investigating the incident.  

 


A long-running debate about the role of AI at war pits those who hope AI will reduce mistakes in war, save lives and deliver victories against campaigners and experts who worry that speeding through targets will make war worse and lead to greater civilian harm. There is also debate about the extent to which technology companies should be privy to how their AI tools are used and whether they should be held responsible for outputs that result in mistakes.

 


Hamza Chaudhry, at the Future of Life Institute, a group that emphasizes the risks of military AI, warns that AI targeting processes could ultimately speed up so fast that nominal human decision-making amounts to little more than a “rubber stamp.” As a result, he said, the expanded scale of combat could result in the taking of many more lives.

 


Amodei’s comments bolster previous reporting from Bloomberg News that AI frontier companies have little oversight of the powerful, sometimes unreliable and potentially deadly tools they are sending into combat. At the same time, the Pentagon is seeking to accelerate its AI adoption on the battlefield.

 


The Anthropic CEO triggered a row with the Trump administration earlier this year by drawing a line at using his company’s AI tools in fully autonomous weapons and mass domestic surveillance. As a result, the Pentagon made the unprecedented decision to designate the US company as a supply-chain risk, triggering a lawsuit from privately held Anthropic that is ongoing.

 


Nevertheless, Amodei’s AI is playing a role in the US war with Iran.

 


US Central Command is using an AI-assisted platform named Maven Smart System that uses Claude and other AI tools to help generate so-called points of interest, help its personnel make decisions and speed up processes for its military operations against Iran. The command has emphasized the unusually high quantity of targets that US operators have hit in a short period of time: striking 1,000 targets in the first 24 hours of operations and 13,000 targets by April 6, little more than a month after operations began.

 


Asked whether he was comfortable with Claude’s role in hitting more targets and helping to kill people more quickly, Amodei said he supported the US having the ability to be more effective militarily, arguing that the ability to be “stronger” deters rather than causes wars.

 


“You basically have to leave policy in the hands of the military decision makers,” he said, noting that a human makes the final decision. 

 


Amodei argued that developing AI warfare could help avoid World War III and help defend Taiwan from invasion from China, so long as the technology wasn’t used without limits or in a way that undermined democratic values.

 


“When I see Russia invading Ukraine, when I see the risk of China invading Taiwan, it worries me that we have a kind of resurgent authoritarian bloc, that they’re very aggressive and that we need to defend ourselves,” he said. 

 

“We don’t want a world where China and Russia can build, can analyze all the intelligence with AI, can use AI for attacking Taiwan and Ukraine, and we can’t defend them,” he added. 


But even some supporters of AI warfare are increasingly wary of the risks involved.

 


“There’s a lot of governance pieces that, in my opinion, are missing,” Jack Shanahan, retired Air Force lieutenant general and former director of Project Maven, the Pentagon effort that birthed Maven Smart System, told a Stanford University workshop devoted to the future of decision-making last week. He warned that integrating Claude into Maven Smart System could lead to unexpected impacts and dilute the role of human judgment.

 


While one advantage of AI is to give humans more time to make decisions, Shanahan said he worried that “Type A” personalities in the military may use that extra time to make more decisions rather than better decisions. 

 


“If you make more decisions rather than the right decisions, you may have a very flawed decision-making process,” he said. “You may have a thousand targets, but are they the right targets?”

 



Source link

Volumes soar at United Spirits Ltd counter

INR gathers momentum as oil pulls back sharply


The Indian rupee gathered momentum in opening trades on Friday as oil prices slumped sharply on improving optimism of a possible peace deal between US and Iran. Rupee opened at Rs 95.40 per dollar and hit a high of 95.18 so far during the day. Yesterday, the counter settled at Rs 95.85. Loal equities are also seen opening on a strong footing after Wall Street’s three major indexes posted their biggest daily gains since April 8 overnight on hopes for a Midde East peace deal. U.S. President Donald Trump claimed an agreement to end the war with Iran had been reached and would be signed shortly, possibly in Europe this weekend with Vice President JD Vance attending on his behalf. NIFTY 50 is trading at 23,368.55, up by 206.95 points (+0.89%) while BSE SENSEX is trading at 74,639.93, up by 807.38 points (+1.09%).

 

Powered by Capital Market – Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

First Published: Jun 12 2026 | 10:04 AM IST



Source link

YouTube
Instagram
WhatsApp